Absci logo

Absci

absci.com

Absci uses generative AI and an integrated drug creation platform to design and optimize biologic drugs, including antibodies, for pharmaceutical companies and patients. Its technology combines AI-driven de novo design, lead optimization, and wet lab validation to create therapeutics against difficult-to-drug targets, aiming to accelerate the development of better biologics for challenging diseases.

Facts

HQ
Vancouver, Wash.
Sectors
Biotechnology Research
Founded
2011
Employees
159
Stage
Public
Members see funding amounts.
.

Is this your organization? Claim it

  • Signed a material agreement Jun 24, 2026
  • Leadership or executive-pay change Mar 6, 2026
  • Signed a material agreement Mar 6, 2026
  • Signed a material agreement Nov 4, 2025
  • Signed a material agreement Jul 25, 2025
  • Leadership or executive-pay change Jul 8, 2025
  • Leadership or executive-pay change Apr 28, 2025
  • Signed a material agreement Feb 28, 2024
  • Leadership or executive-pay change Dec 7, 2023
  • Leadership or executive-pay change Aug 17, 2023
  • Leadership or executive-pay change Aug 14, 2023
  • Signed a material agreement Jun 16, 2023
  • Leadership or executive-pay change Jun 6, 2023
  • Leadership or executive-pay change Nov 2, 2022
  • Leadership or executive-pay change Oct 4, 2022
  • Leadership or executive-pay change Sep 20, 2022
  • Leadership or executive-pay change Jul 14, 2022
  • Leadership or executive-pay change Mar 21, 2022
  • Leadership or executive-pay change Jan 10, 2022
  • Leadership or executive-pay change Aug 24, 2021
  • Filed to go public Jun 30, 2021

People

See all 5
  • Sean McClain Founder, CEO & Director
  • Sean McClain CEO and Founder
  • Sean McClain Founder and CEO

Online